REHOVOT, Israel, Aug. 12,
2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN)
(TASE: EVGN) (the "Company", "Evogene"), a leading
computational biology company targeting to revolutionize
life-science product discovery and development across multiple
market segments, today reported the receipt of a formal
notification from The Nasdaq Stock Market LLC ("Nasdaq")
that the Company has regained compliance with Listing Rule
5550(a)(2), which requires the Company's ordinary shares to
maintain a minimum bid price of $1.00
per share.
The Nasdaq staff made this determination of compliance after the
closing bid price of the Company's ordinary shares was at
$1.00 per share or greater for the
prior 10 consecutive business days. Accordingly, the Company has
regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq
considers the prior bid price deficiency matter now closed.
About Evogene Ltd.:
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational
biology company leveraging big data and artificial intelligence,
aiming to revolutionize the development of life-science-based
products by utilizing cutting-edge technologies to increase the
probability of success while reducing development time and
cost.
Evogene established three unique tech-engines
- MicroBoost AI, ChemPass
AI and GeneRator AI. Each tech-engine is
focused on the discovery and development of products based on one
of the following core components: microbes (MicroBoost AI),
small molecules (ChemPass AI), and genetic elements
(GeneRator AI).
Evogene uses its tech-engines to develop products through
strategic partnerships and collaborations, and its five
subsidiaries including:
- Biomica Ltd. (www.biomicamed.com) developing and
advancing novel microbiome-based therapeutics to treat human
disorders powered by MicroBoost AI;
- Lavie Bio Ltd. (www.lavie-bio.com) -
developing and commercially advancing, microbiome based
ag-biologicals powered by MicroBoost AI;
- AgPlenus Ltd. (www.agplenus.com) -developing next
generation ag chemicals for effective and sustainable crop
protection powered by ChemPass AI;
- Casterra Ag Ltd. (www.casterra.co)– developing and
marketing superior castor seed varieties producing high yield and
high-grade oil content, on an industrial scale for the biofuel and
other industries powered by GeneRator AI.
For more information, please visit: www.evogene.com.
|
Evogene Investor
Contact:
|
|
|
Rachel Pomerantz
Gerber
Head of Investor
Relations at Evogene
rachel.pomerantz@evogene.com
Tel:
+972-8-9311901
|
|
View original
content:https://www.prnewswire.com/news-releases/evogene-regains-compliance-with-nasdaq-minimum-closing-bid-price-rule-302219815.html
SOURCE Evogene